incretin hormones (Drucker Diagnostics)
86
Structured Review
Drucker Diagnostics
incretin hormones
Incretin Hormones, supplied by Drucker Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/incretin+hormone/hormones+incretin/bio_rxiv__64898__2026__04__21__719988-20-9-35
Average 86 stars, based on 1 article reviews
Incretin Hormones, supplied by Drucker Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/incretin+hormone/hormones+incretin/bio_rxiv__64898__2026__04__21__719988-20-9-35
Average 86 stars, based on 1 article reviews
incretin hormones - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
other:Article Title: Venous blood provides lower glucagon-like peptide-1 concentrations than arterialized blood in the postprandial but not the fasted state: Consequences of sampling methods Article Snippet: Since GLP-1 is the major Article Title: In vivo techniques for assessment of insulin sensitivity and glucose metabolism Article Snippet: Am J Physiol Endocrinol Metab 289: E53-61 558 Article Title: [Incretin-based co- and tri-agonists : Innovative polypharmacology for the treatment of obesity and diabetes]. Article Snippet: Background.. The worldwide rise in overweight and obesity is paralleled by an increasing prevalence of type-2 diabetes.. Apart from bariatric surgery, treatment options to decrease body weight are often underwhelming. Article Title: Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease. Article Snippet: Article Title: Characterization of the use of liraglutide for glycemic control in healthy and Type 1 diabetes mellitus suffering dogs. Article Snippet: Glucagon-like peptide 1 (GLP-1) is a glucose-lowering, intestinal-derived factor with multiple physiological effects, making it attractive for diabetes therapy.. However, the therapeutic potential of endogenous GLP-1 is limited, because of rapid inactivation by dipeptidyl peptidase-4.. Recently, enhanced incretin preparations, such as liraglutide, have emerged, which are more resistant to degradation and longer lasting. Article Title: The avian proglucagon system. Article Snippet: Understanding how the proglucagon system functions in maintaining glycemic control and energy balance in birds, as well as defining its specific roles in regulating metabolism, gastrointestinal tract function and food intake requires detailed knowledge of the components that comprise this system.. These include proglucagon, a precursor protein from which glucagon and two glucagon-like peptide hormones (GLP-1 and GLP-2) are derived, and the membrane bound G-protein-coupled receptors that specifically bind glucagon, GLP-1 and GLP-2 to mediate their individual physiological actions.. Another key feature of the proglucagon system that is important for regulating its activity in different tissues involves post-translational processing of the proglucagon precursor protein and the individual peptide hormones derived from it. Article Title: The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson’s Disease Article Snippet: 14 Background: Parkinson’s disease (PD) is a progressive neurodegenerative disease for which there is no cure.. In a clinical trial, the glucagon-like peptide-1 (GLP-1) receptor agonist exendin-4 has shown good protective effects in PD patients.. The hormone glucose-dependent insulinotropic polypeptide (GIP) has also shown protective effects in animal models of PD. |